Clearpointneuro
NASDAQ: CLPT1 known investors
ClearPoint Neuro develops image-guided surgical systems that enable precise navigation to the brain and spine for neurosurgical procedures, drug delivery, and cell and gene therapy applications. The company provides hardware, software, and clinical support services to neurosurgery centers and CNS drug delivery partners worldwide.
Deep TechHealthtechMedical Devices
Investors · 1
Competitors · 3
by search overlapRf Surgical24 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Genhealth21 shared keywordsGenHealth.ai develops generative AI algorithms for healthcare, drawing on standardized FHIR patient data, to support major health decisions. It serves health plans, providers, pharma, and application developers across the healthcare industry.
Seeking Alpha20 shared keywordsSeeking Alpha is a financial research platform that provides stock analysis, investment tools, and market coverage across asset classes to investors. The platform aggregates research from thousands of analysts and investors, offering ratings, articles, and investment ideas.
Companies competing with Clearpointneuro for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Clearpointneuro do?
- ClearPoint Neuro develops image-guided surgical systems that enable precise navigation to the brain and spine for neurosurgical procedures, drug delivery, and cell and gene therapy applications. The company provides hardware, software, and clinical support services to neurosurgery centers and CNS drug delivery partners worldwide.
- Who are Clearpointneuro's investors?
- Clearpointneuro's investors include Oberland Capital.